Country-wise Listing - Libya

To view the articles from different countries, Please click on the country name on left side countries menu.
S.NO Title & Authors Name page
1
Multidrug resistant tuberculosis (MDR-TB): A lethal risk in Benghazi City, Libya
Mohamed F. Abbar; Yousef M. Sherif; Heba J. Majbri; Makarim Elfadil M. Osman and Emadeldin Hassan E. Konozy
 Abstract                  View                 Download                 XML
Anti-tuberculosis (TB) drug resistance is a major public health problem that threatens TB treatment progress made in the inhabitants of countries in Europe, Asia, Africa, and the America. A retrospective study for the pulmonary TB cases admitted to Quefia Chest Hospital Benghazi, Libya, from 1/1/2009 till 1/6/2010 showed that 4 cases out of 430 TB patients were positive for sensitivity culture and didn\'t respond to the first line anti-TB therapy and therefore were diagnosed as Multidrug Resistant Tuberculosis (MDR-TB). One of these patients was Libyan while others were aliens. The 2nd line anti-TB drugs were given in the form of Amikacin injection, cycloserine, moxifloxacin and pyrazinamide for the first 6 months followed by 18 months therapy with moxifloxacin, cycloserine and pyrazinamide. Follow-up with the patients exhibited clinical-radiological and microbiological improvement.
22-27
2
Conference Announcement: 20th World Congress on Advances in Pharmaceutical Sciences
Isaac Bruce
 Abstract                  View                 Download                 XML

The conference “19th World Congress on Advances in Pharmaceutical Sciences” hosted by Conference Series was held during October 14-15, 2019 in Seoul, South Korea was successfully completed with the theme “Potential Challenges and Strategies to Tackle Emerging Pharma Innovations” offered a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. Benevolent response and active participation was received from the scientists, professors, lecturers, pharmaceutical industries, healthcare industries, researchers and students from the fields of pharmaceutical sciences, those who involved in this successful event.

1